Improved conditions for extraction and amplification of human immunodeficiency virus type 1 RNA from plasma samples with low viral load.

Journal of human virology Pub Date : 2000-01-01
M L Villahermosa, M Thomson, E Vázquez de Parga, M T Cuevas, G Contreras, L Pérez-Alvarez, E Delgado, N Manjón, L Medrano, R Nájera
{"title":"Improved conditions for extraction and amplification of human immunodeficiency virus type 1 RNA from plasma samples with low viral load.","authors":"M L Villahermosa,&nbsp;M Thomson,&nbsp;E Vázquez de Parga,&nbsp;M T Cuevas,&nbsp;G Contreras,&nbsp;L Pérez-Alvarez,&nbsp;E Delgado,&nbsp;N Manjón,&nbsp;L Medrano,&nbsp;R Nájera","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>We attempted to define optimal conditions for amplification of low copy number HIV-1 RNA sequences in plasma samples, applying improved conditions for nucleic acid extraction and amplification.</p><p><strong>Methods: </strong>Several methodologic parameters were evaluated, including methods of RNA extraction, volumes of plasma samples, proportion of extracted RNA used as a template for amplification, and reverse transcriptase-DNA polymerase enzyme combination employed in cDNA synthesis and polymerase chain reaction amplification.</p><p><strong>Results: </strong>With this improved assay, we were able to obtain sufficient amounts of amplified material for direct sequencing in 97% of all plasma samples in our study, including 88% of samples with viral loads <80 copies/mL, 78% of samples with viral loads <50 copies/mL, and even 2 (67%) of 3 samples with <20 copies/mL.</p><p><strong>Conclusions: </strong>This procedure could be useful for testing resistance mutations in patients undergoing highly active antiretroviral therapy, in which the viral load is commonly <400 copies/mL, and even if it is <20 RNA copies/mL.</p>","PeriodicalId":80032,"journal":{"name":"Journal of human virology","volume":"3 1","pages":"27-34"},"PeriodicalIF":0.0000,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of human virology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: We attempted to define optimal conditions for amplification of low copy number HIV-1 RNA sequences in plasma samples, applying improved conditions for nucleic acid extraction and amplification.

Methods: Several methodologic parameters were evaluated, including methods of RNA extraction, volumes of plasma samples, proportion of extracted RNA used as a template for amplification, and reverse transcriptase-DNA polymerase enzyme combination employed in cDNA synthesis and polymerase chain reaction amplification.

Results: With this improved assay, we were able to obtain sufficient amounts of amplified material for direct sequencing in 97% of all plasma samples in our study, including 88% of samples with viral loads <80 copies/mL, 78% of samples with viral loads <50 copies/mL, and even 2 (67%) of 3 samples with <20 copies/mL.

Conclusions: This procedure could be useful for testing resistance mutations in patients undergoing highly active antiretroviral therapy, in which the viral load is commonly <400 copies/mL, and even if it is <20 RNA copies/mL.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
改进了从低病毒载量血浆样品中提取和扩增人类免疫缺陷病毒1型RNA的条件。
目的:我们试图确定血浆样品中低拷贝数HIV-1 RNA序列扩增的最佳条件,并应用改进的核酸提取和扩增条件。方法:对几种方法参数进行评估,包括RNA提取方法、血浆样品体积、提取RNA作为扩增模板的比例,以及用于cDNA合成和聚合酶链反应扩增的逆转录酶- dna聚合酶组合。结果:通过这种改进的检测方法,我们能够在97%的血浆样本中获得足够数量的扩增物质进行直接测序,其中包括88%的病毒载量样本。结论:该方法可用于检测接受高活性抗逆转录病毒治疗的患者的耐药突变,其中病毒载量普遍存在
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Associations between MHC class I and susceptibility to HIV-2 disease progression. Positive and negative effects on translation of the hepatitis C virus 3' untranslated region. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments. Abstracts of the 2002 International Meeting of the Institute of Human Virology. September 9-13, 2002, Baltimore, Maryland, USA. The hepatitis C virus NS5B RNA-dependent RNA polymerase activity and susceptibility to inhibitors is modulated by metal cations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1